vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $18.6M, roughly 1.7× ENANTA PHARMACEUTICALS INC). Silvercrest Asset Management Group Inc. runs the higher net margin — -0.4% vs -64.1%, a 63.8% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-11.8M). Over the past eight quarters, ENANTA PHARMACEUTICALS INC's revenue compounded faster (4.5% CAGR vs 2.7%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
ENTA vs SAMG — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $32.0M |
| Net Profit | $-11.9M | $-120.0K |
| Gross Margin | — | — |
| Operating Margin | -60.5% | -2.8% |
| Net Margin | -64.1% | -0.4% |
| Revenue YoY | 9.8% | -0.0% |
| Net Profit YoY | 46.4% | -107.4% |
| EPS (diluted) | $-0.42 | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $32.0M | ||
| Q3 25 | $15.1M | $31.3M | ||
| Q2 25 | $18.3M | $30.7M | ||
| Q1 25 | $14.9M | $31.4M | ||
| Q4 24 | $17.0M | $32.0M | ||
| Q3 24 | $14.6M | $30.4M | ||
| Q2 24 | $18.0M | $31.0M | ||
| Q1 24 | $17.1M | $30.3M |
| Q4 25 | $-11.9M | $-120.0K | ||
| Q3 25 | $-18.7M | $618.0K | ||
| Q2 25 | $-18.3M | $1.9M | ||
| Q1 25 | $-22.6M | $2.5M | ||
| Q4 24 | $-22.3M | $1.6M | ||
| Q3 24 | $-28.8M | $2.3M | ||
| Q2 24 | $-22.7M | $2.7M | ||
| Q1 24 | $-31.2M | $3.0M |
| Q4 25 | -60.5% | -2.8% | ||
| Q3 25 | -121.6% | 4.3% | ||
| Q2 25 | -103.2% | 13.2% | ||
| Q1 25 | -164.3% | 15.4% | ||
| Q4 24 | -138.8% | 6.1% | ||
| Q3 24 | -204.4% | 14.6% | ||
| Q2 24 | -134.6% | 17.1% | ||
| Q1 24 | -192.1% | 19.5% |
| Q4 25 | -64.1% | -0.4% | ||
| Q3 25 | -123.6% | 2.0% | ||
| Q2 25 | -99.7% | 6.3% | ||
| Q1 25 | -151.7% | 7.9% | ||
| Q4 24 | -131.4% | 5.1% | ||
| Q3 24 | -197.3% | 7.4% | ||
| Q2 24 | -126.1% | 8.6% | ||
| Q1 24 | -182.7% | 9.9% |
| Q4 25 | $-0.42 | $0.02 | ||
| Q3 25 | $-0.88 | $0.07 | ||
| Q2 25 | $-0.85 | $0.21 | ||
| Q1 25 | $-1.06 | $0.26 | ||
| Q4 24 | $-1.05 | $0.16 | ||
| Q3 24 | $-1.36 | $0.24 | ||
| Q2 24 | $-1.07 | $0.28 | ||
| Q1 24 | $-1.47 | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $126.6M | $50.3M |
| Total Assets | $329.5M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | $44.1M | ||
| Q3 25 | $32.3M | $36.1M | ||
| Q2 25 | $44.8M | $30.0M | ||
| Q1 25 | $60.2M | $36.3M | ||
| Q4 24 | $84.3M | $68.6M | ||
| Q3 24 | $37.2M | $58.1M | ||
| Q2 24 | $35.8M | $49.9M | ||
| Q1 24 | $63.5M | $39.7M |
| Q4 25 | $126.6M | $50.3M | ||
| Q3 25 | $64.7M | $58.9M | ||
| Q2 25 | $79.3M | $64.6M | ||
| Q1 25 | $93.5M | $80.0M | ||
| Q4 24 | $111.8M | $80.7M | ||
| Q3 24 | $128.8M | $84.6M | ||
| Q2 24 | $148.9M | $85.3M | ||
| Q1 24 | $166.1M | $83.9M |
| Q4 25 | $329.5M | $166.6M | ||
| Q3 25 | $280.7M | $157.6M | ||
| Q2 25 | $301.0M | $152.7M | ||
| Q1 25 | $323.0M | $159.9M | ||
| Q4 24 | $348.6M | $194.4M | ||
| Q3 24 | $376.7M | $184.2M | ||
| Q2 24 | $398.8M | $177.6M | ||
| Q1 24 | $413.6M | $170.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $18.6M |
| Free Cash FlowOCF − Capex | $-11.8M | $15.0M |
| FCF MarginFCF / Revenue | -63.6% | 46.9% |
| Capex IntensityCapex / Revenue | 0.8% | 11.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $18.6M | ||
| Q3 25 | $-6.5M | $14.6M | ||
| Q2 25 | $17.5M | $13.8M | ||
| Q1 25 | $-13.5M | $-24.7M | ||
| Q4 24 | $-16.8M | $21.6M | ||
| Q3 24 | $-10.4M | $13.3M | ||
| Q2 24 | $-14.8M | $16.0M | ||
| Q1 24 | $-28.6M | $-24.1M |
| Q4 25 | $-11.8M | $15.0M | ||
| Q3 25 | $-7.9M | $13.8M | ||
| Q2 25 | $17.4M | $13.4M | ||
| Q1 25 | $-16.0M | $-25.1M | ||
| Q4 24 | $-25.5M | $19.9M | ||
| Q3 24 | $-19.4M | $12.9M | ||
| Q2 24 | $-21.3M | $15.6M | ||
| Q1 24 | $-30.3M | $-24.7M |
| Q4 25 | -63.6% | 46.9% | ||
| Q3 25 | -52.5% | 44.1% | ||
| Q2 25 | 94.7% | 43.6% | ||
| Q1 25 | -107.4% | -80.0% | ||
| Q4 24 | -150.6% | 62.2% | ||
| Q3 24 | -132.5% | 42.4% | ||
| Q2 24 | -118.6% | 50.4% | ||
| Q1 24 | -177.5% | -81.6% |
| Q4 25 | 0.8% | 11.4% | ||
| Q3 25 | 9.6% | 2.6% | ||
| Q2 25 | 0.8% | 1.5% | ||
| Q1 25 | 17.0% | 1.3% | ||
| Q4 24 | 51.6% | 5.3% | ||
| Q3 24 | 61.3% | 1.2% | ||
| Q2 24 | 36.4% | 1.1% | ||
| Q1 24 | 9.8% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | 23.62× | ||
| Q2 25 | — | 7.22× | ||
| Q1 25 | — | -10.01× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 5.90× | ||
| Q2 24 | — | 6.00× | ||
| Q1 24 | — | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTA
Segment breakdown not available.
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
